Special Resolutions available at NSM
12 May 2017
ConvaTec Group Plc
ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting on 11 May 2017 and the results of the poll were published that day.
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.
For further information, please contact Clare Bates, Company Secretary (0118 952 8100).
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
Enquiries
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
[email protected]
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Rebecca Fitchett, Finsbury +44 (0)207 251 3801
# # #
END
